Thrombophilia and unexplained pregnancy loss in Indian patients

National Medical Journal of India

Volumn 21, Issue 3, 2008, Pages 116-119

  Vora, Sonal ^a   Shetty, Shrimati ^a   Salvi, Vinita ^a   Satoskar, Purnima ^b   Ghosh, Kanjaksha ^a  

^a KEM HOSPITAL   (India)

^b Nowrosjee Wadia Maternity Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; BETA2 GLYCOPROTEIN 1; BLOOD CLOTTING FACTOR 5 LEIDEN; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LIPOCORTIN 5; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FETUS WASTAGE; GENETIC POLYMORPHISM; HUMAN; INDIA; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; PREGNANCY OUTCOME; PROTHROMBIN TIME; RISK FACTOR; SCREENING TEST; THROMBIN TIME; THROMBOPHILIA;

ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; ANTIBODIES, ANTICARDIOLIPIN; BIOLOGICAL MARKERS; BLOOD COAGULATION TESTS; FEMALE; GENETIC MARKERS; HUMANS; INDIA; MASS SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; RISK FACTORS; THROMBOPHILIA; YOUNG ADULT;

EID: 53849120545     PISSN: 0970258X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Whittaker PG, Taylor A, Lind T. Unsuspected pregnancy loss in healthy women. Lancet 1983;1:1126-7.
2. Wilcox AJ, Weinberg CR. O'Connor JF, Baird DD, Schlatterer JP, Canfield RE, et al. Incidence of early loss of pregnancy. N Engl J Med 1988;319:189-94.
3. Edmonds DK, Lindsay KS, Miller JF, Williamson E, Wood PJ. Early embryonic mortality in women. Fertil Steril 1982;38:447-53.
4. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999;340:9-13.
5. Walker ID. Thrombophilia in pregnancy. J Clin Pathol 2000; 53:573-80.
6. Exner T, Rickard KA, Kronenberg H. A sensitive test demonstrating lupus anticoagulant and its behavioural patterns. Br J Haematol 1978; 40:143-51.
7. Thiagarajan P, Pengo V, Shapiro SS. The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants. Blood 1986;68:869-74.
8. Sambrook J, Fritsch EF, Maniatis T, Molecular cloning: A laboratory manual. New York:Cold Spring Harbor Laboratory Press, 1989.
9. Arruda VR, Annichino-Bizzacchi JM, Costa FF, Reitsma PH. Factor V Leiden (FVQ 506) is common in a Brazilian population. Am J Hematol 1995;49:242-3.
10. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3695-703.
11. Abbate R, Sardi I, Pepe G, Marcucci R, Brunelli T, Prisco D, et al. The high prevalence of thermolabile 5-10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD). Thromb Haemost 1998;79:727-30.
12. Akar N, Gokdemir R, Ozel D, Akar E. Endothelial cell protein C receptor (EPCR) gene exon III, 23 bp insertion mutation in the Turkish pediatric thrombotic patients. Thromb Haemost 2002;88:1068-9.
13. Morange PE, Henry M, Tregouet D, Granel B, Aillaud MF, Alessi MC, et al. The A-844G polymorphism in the PAI-1 gene is associated with a higher risk of venous thrombosis in factor V Leiden carriers. Arterioscler Thromb Vasc Biol 2000;20: 1387-91.
14. Costa Hde L, de Moura MD, Ferriani RA, Anceschi MI, Barbosa JE. Prevalence of anti-cardiolipin antibody in habitual aborters. Gynecol Obstet Invest 1993;36:221-5.
15. Nielsen HS, Christiansen OB. Prognostic impact of anticardiolipin antibodies in women with recurrent miscarriage negative for the lupus anticoagulant. Hum Reprod 2005;20:1720-8.
16. Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD, et al. Thrombophilia in pregnancy: A systematic review. Br J Haematol 2006;132:171-96.
17. Bocciolone L, Meroni P, Parazzini F, Tincani A, Radici E, Tarantini M, et al. Antiphospholipid antibodies and risk of intrauterine late fetal death. Acta Obstet Gynecol Scand 1994;73:389-92.
18. Gris JC, Quere I, Monpeyroux F, Mercier E, Ripart-Neveu S, Tailland ML, et al. Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent - the Nimes Obstetricians and Haematologists Study 5 (NOHA5). Thromb Haemost 1999;81:891-9.
19. Das I, Vasishta K, Dash S. Study of lupus anticoagulant in pregnant women with recurrent abortion. Aust N Z J Obstet Gynaecol 1991; 31:323-6.
20. Ogasawara M, Aoki K, Matsuura E, Sasa H, Yagami Y. Anti beta 2 glycoprotein I antibodies and input anticoagulant in patients with recurrent pregnancy loss: Prevalence and clinical significance. Lupus 1996;5:587-92.
21. Ghosh K, Shetty S, Madkaikar M, Pawar A, Nair S, Khare A, et al. Venous thromboembolism in young patients from western India: A study. Clin Appl Thromb Hemost 2001;7:158-65.
22. Many A, Elad R, Yaron Y, Eldor A, Letting JB, Kupferminc MJ. Third-trimester unexplained intrauterine fetal death is associated with inherited thrombophilia. Obstet Gynecol 2002;99:684-7.
23. Raziel A, Kornberg Y, Friedler S, Schachter M, Sela BA, Ron-El R. Hypercoagulable thrombophilic defects and hyperhomocysteinemia in patients with recurrent pregnancy loss. Am J Reprod Immunol 2001;45:65-71.
24. Brenner B, Sarig G, Weiner Z, Younis J, Blumenfeld Z, Lanir N. Thrombophilic polymorphisms are common in women with fetal loss without apparent cause. Thromb Haemost 1999;82:6-9.
25. Carp H, Salomon O, Seidman D, Dardik R, Rosenberg N, Inbal A. Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss. Hum Reprod 2002;17:1633-7.
26. Alfirevic Z, Mousa HA, Martlew V, Briscoe L, Perez-Casal M, Toh CH. Postnatal screening for thrombophilia in women with severe pregnancy complications. Obstet Gynecol 2001;97:753-9.
27. Nelen WL, Blom HJ, Steegers EA, den Heijer M, Eskes TK. Hyperhomocysteinemia and recurrent early pregnancy loss: A meta-analysis. Fertil Steril 2000:74:1196-9.
28. Franchi F, Biguzzi E, Cetin I, Facchetti F, Radaelli T, Bozzo M, et al. Mutations in the thrombomodulin and endothelial protein C receptor genes in women with late fetal loss. Br J Haematol 2001;114:641-6.
29. Eriksson P, Kallin B, van't Hooft FM, Bavenholm P, Hamsten A. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci U S A 1995;92:1851-5.
30. Zoller B, Garcia de Frutos P, Dahlback B. A common 4G allele in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency. Thromb Haemost 1998;79:802-7.
31. Vora S, Ghosh K, Shetty S, Salvi V, Satoskar P. Deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western India. Thromb J 2007;5:9.
32. Preston FE, Rosendaal FR, Walker ID, Briet E, Berntorp E, Conard J. et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996;348:913-16.
33. Stern JJ, Dorfmann AD, Gutierrez-Najar AJ, Cerrillo M, Coulam CB. Frequency of abnormal karyotypes among abortuses from women with and without a history of recurrent spontaneous abortion. Fertil Steril 1996;65:250-3.
34. Clifford K, Flanagan AM, Regan L. Endometrial CD56+ natural killer cells in women with recurrent miscarriage: A histomorphometric study. Hum Reprod 1999;14:2727-30.